Edesa Biotech Inc. (NASDAQ: EDSA) Stock Information | RedChip

Edesa Biotech Inc. (NASDAQ: EDSA)


$1.6500
-0.1000 ( -7.30% ) 8.2K

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Market Data


Open


$1.6500

Previous close


$1.7500

Volume


8.2K

Market cap


$6.07M

Day range


$1.7450 - $2.0500

52 week range


$1.5500 - $5.9900

SEC Filings


Form Type Description Pages Date
10-k/a Quarterly Reports 16 Dec 20, 2024
10-k Annual reports 88 Dec 13, 2024
8-k 8K-related 15 Dec 13, 2024
4 Insider transactions 1 Dec 03, 2024
4 Insider transactions 1 Nov 12, 2024
4 Insider transactions 1 Nov 01, 2024
8-k 8K-related 71 Oct 31, 2024
8-k 8K-related 18 Oct 04, 2024
4 Insider transactions 1 Oct 02, 2024
4 Insider transactions 1 Sep 03, 2024

Latest News